Plain-English translation of NCT04135664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
After a minimally invasive procedure called endoscopic submucosal dissection (ESD) removes early-stage esophageal cancer, doctors typically recommend additional treatment to reduce the risk of cancer returning. This trial compares two standard follow-up approaches: having surgery to remove the esophagus, or receiving chemotherapy combined with radiation therapy. Researchers want to see which approach gives patients the best long-term survival while maintaining a good quality of life.
Surgery to remove the esophagus works well but is major surgery with serious risks and side effects that can affect how patients eat and live afterward. Recent studies suggest that chemotherapy and radiation may work just as well without requiring surgery. This trial will definitively compare the two approaches to help doctors and patients make the best treatment choice.
You likely qualify if…
You likely don't qualify if…
If you qualify and agree to join, you will be randomly assigned to receive either surgery or chemotherapy plus radiation therapy. You will visit the study center regularly for treatment, monitoring, and follow-up visits over several years. Researchers will track how well you are doing, whether your cancer returns, how you feel, and your overall health and quality of life — with the goal of following you for at least 5 years to see long-term results.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China